Sleep EEG Provides Biomarkers in Depression



Patients with depression frequently report impaired sleep. Objective sleep is recorded by sleep electroencephalogram (EEG). Characteristic sleep-EEG changes in affective disorders include disinhibition of rapid-eye-movement (REM) sleep (shortened REM latency, prolonged first REM periods, elevated REM density, and a measure of the amount of REMs), impaired sleep continuity and changes of nonREM sleep (decreases of slow wave sleep and stage 2 sleep). Disinhibition of REM sleep is also found in animal models of depression. Elevated REM density characterises an endophenotype in high-risk subjects with a positive family history of affective disorders. Most, but not all, antidepressants suppress REM sleep in patients, healthy volunteers and laboratory animals, whereas nonREM sleep and sleep continuity are either impaired or improved by these drugs. Certain sleep-EEG variables or groups of variables appear to predict the response to antidepressive pharmacotherapy or the long-term course of the illness. Overactivity of the hypothalamo-pituitary-adrenocortical system contributes to the sleep-EEG changes in depression. Sleep-EEG variables appear to provide biomarkers for the course of depression and for the screening of antidepressants.


Slow Wave Sleep nonREM Sleep Delta Power Sleep Continuity Intermittent Wakefulness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Adenocorticotropic hormone


Corticotropin-releasing hormone

DEX-CRH test

Dexamethasone/corticotropin-releasing hormone test




High anxiety-related behavior mice


Hamilton Depression Score

HL mice

Helpless mice

HPA system

Hypothalamo-pituitary adrenocortical system


5-Hydroxytryptamine (=serotonin)

LAB mice

Low anxiety-related behavior mice


Selective noradrenaline reuptake inhibitors


Nonhelpless mice


Rapid eye movement


Shortened REM latency or sleep onset REM periods


Selective serotonin and noradrenaline reuptake inhibitors


Selective serotonin reuptake inhibitors


Slow-wave activity


  1. Adrian J, Dugovic C, Martin P (1991) Sleep-wakefulness patternsin the helpless rat. Physiol Behav 49:257–262CrossRefGoogle Scholar
  2. Akindele MO, Evans JI, Oswald I (1970) Monoamine oxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol 29:47–56PubMedCrossRefGoogle Scholar
  3. AllisonT, Van Twyver H (1970) The evolution of sleep. Nat Hist 79:56–65Google Scholar
  4. Ansseau M, Kupfer DJ, Reynolds CF, III, McEachran AB (1984) REM latency distribution in major depression: clinical characteristics associated with sleep onset REM periods. Biol Psychiatr 1651–1666Google Scholar
  5. Antonijevic IA, Steiger A (2003) Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis. Psychoneuroendocrinology 28:780–795PubMedCrossRefGoogle Scholar
  6. Antonijevic IA, Murck H, Frieboes RM, Holsboer F, Steiger A (1999) On the gender differences in sleep-endocrine regulation in young normal humans. Neuroendocrinology 70:280–287PubMedCrossRefGoogle Scholar
  7. Armitage R (2007) Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand 115:104–115CrossRefGoogle Scholar
  8. Aslan S, Isik E, Cosar B (2002) The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep 25:677–679PubMedGoogle Scholar
  9. Benca RM, Okawa M, Uchiyama M, Ozaki S, Nakajima T, Shibui K, Obermeyer WH (1997) Sleep and mood disorders. Sleep Med Rev 1:45–56PubMedCrossRefGoogle Scholar
  10. Borbély AA (1982) A two process model of sleep regulation. Hum Neurobiol 1:195–206PubMedGoogle Scholar
  11. Borbély AA, Tobler I, Loepfe M, Kupfer DJ, Ulrich RF, Grochocinski V, Doman J, Matthews G (1984) All-night spectral analysis of the sleep EEG in untreated depressives and normal controls. Psychiatr Res 12:27–33CrossRefGoogle Scholar
  12. BouyerJJ, Vallée M, Deminière JM, Le Moal M, Mayo W (1998) Reaction of sleep-wakefulness cycle to stress in related to differences in hypothalamo-pituitary-adrenal axis reactivity in rat. Brain Res 804:114–124PubMedCrossRefGoogle Scholar
  13. Buckley TM, Schatzberg AF (2005) On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: Normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90:3106–3114PubMedCrossRefGoogle Scholar
  14. Buysse DJ, Tu XM, Cherry CR, Begley AE, Kowalski J, Kupfer DJ, Frank E (1999) Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biol Psychiatr 45:205–213CrossRefGoogle Scholar
  15. Buysse DJ, Hall M, Begley A, Cherry CR, Houck PR, Land S, Ombao H, Kupfer DJ, Frank E (2001) Sleep and treatment response in depression: new findings using power spectral analysis. Psychiatr Res 103:51–67CrossRefGoogle Scholar
  16. Chen CN (1979) Sleep, depression and antidepressants. Br J Psychiatr 135:385–402CrossRefGoogle Scholar
  17. Coble PA, Kupfer DJ, Spiker DG, Neil JF, McPartland RJ (1979) EEG sleep in primary depression. A longitudinal placebo study. J Affect Disord 1:131–138CrossRefGoogle Scholar
  18. Cohen RM, Pickar D, Garnett D, Lipper S, Gillin JC, Murphy DL (1982) REM sleep suppression induced by selective monoamine oxidase inhibitors. Psychopharmacology 78:137–140PubMedCrossRefGoogle Scholar
  19. Cramer H, Ohlmeier D (1967) Ein Fall von Tranylcypromin und Trifluoperazin -(Jatrosom)-Sucht: Psychopathologische, schlafphysiologische und biochemische Untersuchungen. Arch Psychiatr Nervenkr 210:182–197PubMedCrossRefGoogle Scholar
  20. Dugovic C, Maccari S, Weibel L, Turek FW, Van Reeth O (1999) High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 19:8656–8664PubMedGoogle Scholar
  21. Dugovic C, Solberg LC, Redei E, Van Reeth O, Turek FW (2000) Sleep in the Wister-Kyoto rat, a putative genetic animal model for depression. Neuroreport 11:627–631PubMedCrossRefGoogle Scholar
  22. Dunleavy DL, Oswald I (1973) Phenelzine, mood response, and sleep. Arch Gen Psychiatr 28:353–356PubMedCrossRefGoogle Scholar
  23. Dunleavy DL, Brezinova V, Oswald I, MacLean AW, Tinker M (1972) Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br J Psychiatr 120:663–672CrossRefGoogle Scholar
  24. Ehlers CL, Reed TK, Henriksen SJ (1986) Effects of corticotropin-releasing factor and growth hormone- releasing factor on sleep and activity in rats. Neuroendocrinology 42:467–474PubMedCrossRefGoogle Scholar
  25. El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, Hamon M, Costentin J, Adrian J, Vaugeois J-M (2003) Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci USA 100:6227–6623PubMedCrossRefGoogle Scholar
  26. Feinberg M, Gillin JC, Carroll BJ, Greden JF, Zis AP (1982) EEG studies of sleep in the diagnosis of depression. Biol Psychiatr 17:305–316Google Scholar
  27. Gillin JC, Wyatt RJ, Fram D, Snyder F (1978) The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 59:267–272PubMedCrossRefGoogle Scholar
  28. Gillin JC, Sitaram N, Wehr T, Duncan W, Post R, Murphy DL, Wyatt RJ, Bunney WE (1984) Sleep and affective illness. In: Post RM, Ballenger, JC Neurobiology of mood disorders. Williams and Wilins, Baltimore, pp 157–189Google Scholar
  29. Goetz RR, Puig-Antich J, Ryan N, Rabinovich H, Ambrosini PJ, Nelson B, Krawiec V (1987) Electroencephalographic sleep of adolescents with major depression and normal controls. Arch Gen Psychiatr 44:61–68PubMedCrossRefGoogle Scholar
  30. GrønliJ, Murison R, Bjørvatn B, Sørensen E, Portas CM, Ursin R (2004) Chronic mild stress affects sucrose intake and sleep in rats. Behav Brain Res 150:139–147PubMedCrossRefGoogle Scholar
  31. Grözinger M, Kogel P, Röschke J (2002) Effects of REM sleep awakenings and related wakening paradigms on the ultradian sleep cycle and the symptoms in depression. J Psychiatr Res 36:299–308PubMedCrossRefGoogle Scholar
  32. Hatzinger M, Hemmeter UM, Brand S, Ising M, Holsboer-Trachsler E (2004) Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response. J Psychiatr Res 38:453–465PubMedCrossRefGoogle Scholar
  33. Hatzinger M, Brand S, Perren S, Stadelmann S, von Wyl A, von Klitzing K, Holsboer-Trachsler E (in press) Electroencephalographic sleep profiles and hypothalamic-pituitary-adrenocortical (HPA) activity in kindergarten children: Early indication of poor sleep quality associated with increased cortisol secretion. J Psychiatr ResGoogle Scholar
  34. Hawkins DR, Taub JM, Van de Castle RL (1985) Extended sleep (hypersomnia) in young depressed patients. Am J Psychiatr 142:905–910PubMedGoogle Scholar
  35. Heiligenstein JH, Faries DE, Rush AJ, Andersen JS, Pande AC, Roffwarg HP, Dunner D, Gillin JC, James SP, Lahmeyer H (1994) Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients. Psychiatr Res 52:327–339CrossRefGoogle Scholar
  36. Held K, Künzel H, Ising M, Schmid DA, Zobel A, Murck H, Holsboer F, Steiger A (2004) Treatment with the CRH1. -receptor antagonist R121919 improves sleep EEG in patients with depression J Psychiatr Res 38:129–136PubMedCrossRefGoogle Scholar
  37. Henn FA, Vollmayr B (2005) Stress models of depression: Forming genetically vulnerable strains. Neurosci Behav Rev 29:799–804CrossRefGoogle Scholar
  38. Holsboer F, von Bardeleben U, Steiger A (1988) Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 48:32–38PubMedCrossRefGoogle Scholar
  39. Hudson JI, Lipinski JF, Frankenburg FR, Grochocinski VJ, Kupfer DJ (1988) Electroencephalographic sleep in mania. Arch Gen Psychiatr 45:267–273PubMedCrossRefGoogle Scholar
  40. Insel TR, Gillin C, Moore A, Wallace B.M., Loewenstein RJ, Murphy DL (1982) The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatr 39:1372–1377PubMedCrossRefGoogle Scholar
  41. Jindal RD, Thase ME, Fasiczka AL, Friedman ES, Buysse DJ, Frank E, Kupfer DJ (2002) Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. Comparison during remission. Biol Psychiatr 51:230–236Google Scholar
  42. Katz JL, Kuperberg A, Pollack CP, Walsh BT, Zumoff B, Weiner H (1984) Is there a relationship between eating disorder and affective disorder? New evidence from sleep recordings. Am J Psychiatr 141:753–759PubMedGoogle Scholar
  43. KimuraM, Müller-Preuss P, Wiesner E, Lu A, Deussing JM (2006) Site-specific CRH overexpression alters sleep in transgenic mice. J Sleep Res 15 (Suppl 1): 101Google Scholar
  44. Kimura M, Müller-Preuss P, Wiesner E, Flachskamm C, Lu A, Deussing JM (2007) REM sleep enhancement in CNS-specific CRH-overexpressing mice. Neurosci Res 58 (Suppl 1):S32CrossRefGoogle Scholar
  45. Kluge M, Schüssler P, Steiger A (2007) Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression. Eur Neuropsychopharmacol 17:527–531PubMedCrossRefGoogle Scholar
  46. Künzel HE, Murck H, Held K, Ziegenbein M, Steiger A (2004) Reboxetine induces similar sleep EEG changes like SSRI`s in patients with depression. Pharmacopsychiatry 37:193–195CrossRefGoogle Scholar
  47. Kupfer DJ (1976) REM latency: A psychobiologic marker for primary depressive disease. Biol Psychiatr 11:159–174Google Scholar
  48. Kupfer DJ, Foster FG (1972) Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet 2:684–686PubMedCrossRefGoogle Scholar
  49. Kupfer DJ, Foster FG, Reich L, Thompson SK, Weiss B (1976) EEG sleep changes as predictors in depression. Am J Psychiatr 133:622–626PubMedGoogle Scholar
  50. Kupfer DJ, Coble P, Kane J, Petti T, Conners CK (1979) Imipramine and EEG sleep in children with depressive symptoms. Psychopharmacology 60:117–123PubMedCrossRefGoogle Scholar
  51. Kupfer DJ, Spiker DG, Rossi A, Coble PA, Shaw D, Ulrich R (1982) Nortriptyline and EEG sleep in depressed patients. Biol Psychiatr 17:535–546Google Scholar
  52. Kupfer DJ, Ulrich RF, Coble PA, Jarrett DB, Grochocinski VJ, Doman J, Matthews G, Borbély AA (1984) Application of automated REM and slow wave sleep analysis: II. Testing the assumptions of the two-process model of sleep regulation in normal and depressed subjects. Psychiatr Res 13:335–343Google Scholar
  53. Kupfer DJ, Reynolds CF, III, Grochocinski VJ, Ulrich RF, McEachran A (1986a) Aspects of short REM latency in affective states: a revisit. Psychiatr Res 17:49–59CrossRefGoogle Scholar
  54. Kupfer DJ, Reynolds CF3, Ulrich RF, Grochocinski VJ (1986b) Comparison of automated REM and slow-wave sleep analysis in young and middle-aged depressed subjects. Biol Psychiatr 21:189–200CrossRefGoogle Scholar
  55. Kupfer DJ, Ehlers CL, Frank E, Grochocinski VJ, McEachran AB (1991) EEG sleep profiles and recurrent depression. Biol Psychiatr 30:641–655CrossRefGoogle Scholar
  56. Lahmeyer HW, Poznanski EO, Bellur SN (1983) EEG sleep in depressed adolescents. Am J Psychiatr 140:1150–1153PubMedGoogle Scholar
  57. LancelM, Müller-Preuss P, Wigger A, Landgraf R, Holsboer F (2002) The CRH1 receptor antaginist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety. J Psychiatr Res 36:197–208PubMedCrossRefGoogle Scholar
  58. Landolt HP, de Boer LP (2001) Effect of chronic phenelzine treatment on REM sleep: report of three patients. Neuropsychopharmacology 25 (Suppl 5):S63–S67PubMedCrossRefGoogle Scholar
  59. Landolt HP, Raimo EB, Schnierow BJ, Kelsoe JR, Rapaport MH, Gillin JC (2001) Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. Arch Gen Psychiatr 58:268–276PubMedCrossRefGoogle Scholar
  60. Lauer CJ, Krieg JC, Riemann D, Zulley J, Berger M (1990) A polysomnographic study in young psychiatric inpatients: major depression, anorexia nervosa, bulimia nervosa. J Affect Disord 18:235–245PubMedCrossRefGoogle Scholar
  61. Lauer C, Riemann D, Wiegand M, Berger M (1991) From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatr 29:979–993Google Scholar
  62. Lauer CJ, Krieg JC, Garcia-Borreguero D, Özdaglar A, Holsboer F (1992) Panic disorder and major depression: A comparative electroencephalogramic sleep study. Psychiatr Res 44:41–54CrossRefGoogle Scholar
  63. Lauer CJ, Schreiber W, Holsboer F, Krieg JC (1995) In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatr 52:145–153PubMedCrossRefGoogle Scholar
  64. Lauer CJ, Modell S, Schreiber W, Krieg JC, Holsboer F (2004) Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86. J Clin Psychopharmacol 24:356–357PubMedCrossRefGoogle Scholar
  65. Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, Copinschi G, Van Cauter E (1987) 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 65:141–152PubMedCrossRefGoogle Scholar
  66. Lu A, Steiner M, Engelholm M, Wotjak CT, Holsboer F, Wurst W, Deussing JM (2005) Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain - modelling central CRH system hyperactivity. Pharmacopsychiatry 38:261CrossRefGoogle Scholar
  67. Marinesco S, Bonnet C, Cespuglio R (1999) Influence of stress duration on the sleep rebound induced by immobilization in the rat: a possible role for corticosterone. Neuroscience 92:921–933PubMedCrossRefGoogle Scholar
  68. Modell S, Ising M, Holsboer F, Lauer CJ (2002) The Munich vulnerability study on affective disorders: Stability of polysomnographic findings over time. Biol Psychiatr 52:430–437CrossRefGoogle Scholar
  69. Modell S, Ising M, Holsboer F, Lauer CJ (2005) The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol Psychiatr 58:694–699CrossRefGoogle Scholar
  70. Murck H, Frieboes RM, Antonijevic IA, Steiger A (2001) Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A. agonist EMD 68843 on the sleep EEG in healthy men Psychopharmacology 155:187–192PubMedCrossRefGoogle Scholar
  71. Murck H, Nickel T, Künzel H, Antonijevic IA, Schill J, Zobel A, Steiger A, Sonntag A, Holsboer F (2003) State markers of depression in sleep EEG: Dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology 28:348–358PubMedCrossRefGoogle Scholar
  72. Nofzinger EA, Reynolds CF3, Thase ME, Frank E, Jennings JR, Fasiczka AL, Sullivan LR, Kupfer DJ (1995) REM sleep enhancement by bupropion in depressed men. Am J Psychiatr 152:274–276PubMedGoogle Scholar
  73. Opp M, Obál FJr, Krueger JM (1989) Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol 257:R528–R535PubMedGoogle Scholar
  74. Overstreet DH, Friedman E, Mathé AA, Yadid G (2005) The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29:739–759PubMedCrossRefGoogle Scholar
  75. Passouant P, Cadilhac J, Billiard M, Besset A (1973) La suppression du sommeil paradoxal par la clomipramine. Thérapie 28:379–392PubMedGoogle Scholar
  76. Puig-Antich J, Goetz R, Hanlon C, Davies M, Thompson J, Chambers WJ, Tabrizi MA, Weitzman ED (1982) Sleep architecture and REM sleep measures in prepubertal children with major depression: a controlled study. Arch Gen Psychiatr 39:932–939PubMedCrossRefGoogle Scholar
  77. Rechtschaffen A, Kales A (1968) A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects.US Department of Health, Education & Welfare, Neurological Information Network, Bethesda, MDGoogle Scholar
  78. Reich L, Weiss BL, Coble P, McPartland R, Kupfer DJ (1975) Sleep disturbance in schizophrenia. A revisit. Arch Gen Psychiatr 32:51–55CrossRefGoogle Scholar
  79. Reynolds CF3, Kupfer DJ (1987) Sleep research in affective illness: state of the art circa 1987. Sleep 10:199–215PubMedGoogle Scholar
  80. Riemann D, Berger M, (1990) The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. Acta Psychiatr Scand 81:24–31PubMedCrossRefGoogle Scholar
  81. RiemannD, HohagenF, LauerC, Berger M (1991)Longterm evolution of sleep in depression. In:SmirneS, FranceschiMFerini-StrambiLSleep and aging. Masson, Paris, pp 195–204Google Scholar
  82. Ruigt GSF, Kemp B, Groenhout CM, Kamphuisen HA (1990) Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 38:551–554PubMedCrossRefGoogle Scholar
  83. Rush AJ, Erman MK, Giles DE, Schlesser MA, Carpenter G, Vasavada N, Roffwarg HP (1986) Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatr 43:878–884PubMedCrossRefGoogle Scholar
  84. Rush AJ, Giles DE, Jarrett RB, Feldman-Koffler F, Debus JR, Weissenburger J, Orsulak PJ, Roffwarg HP (1989) Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatr 26:61–72CrossRefGoogle Scholar
  85. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, See WR (1991) Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 14:439–447PubMedGoogle Scholar
  86. Schmid DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, Weikel J, Sonntag A, Steiger A (2006) Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin and leptin and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology 31:832–844PubMedCrossRefGoogle Scholar
  87. Schmidt HS, Nofzinger EA, (1988) Short REM latency in impotence without depression. Biol Psychiatr 24:25–32CrossRefGoogle Scholar
  88. Schreiber W, Lauer CJ, Krumrey K, Holsboer F, Krieg JC (1992) Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorders. Biol Psychiatr 32:79–90CrossRefGoogle Scholar
  89. Schulz H, Lund R, Doerr P (1978) The measurement of change in sleep during depression and remission. Arch Psychiatr Nervenkr 225:233–245PubMedCrossRefGoogle Scholar
  90. Schulz H, Lund R, Cording C, Dirlich G (1979) Bimodal distribution of REM sleep latencies in depression. Biol Psychiatr 14:595–600Google Scholar
  91. Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ (1996) The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 126:50–54PubMedCrossRefGoogle Scholar
  92. Shipley JE, Kupfer DJ, Dealy RS, Griffin SJ, Coble PA, McEachran AB, Grochocinski VJ (1984) Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram of depressed patients. Clin Pharmacol Ther 36:251–259PubMedCrossRefGoogle Scholar
  93. Shipley JE, Kupfer DJ, Griffin SJ, Dealy RS, Coble PA, McEachran AB, Grochocinski VJ, Ulrich R, Perel JM (1985) Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients. Psychopharmacology 85:14–22PubMedCrossRefGoogle Scholar
  94. Shiromani PJ, Overstreet DH, Levy d, Goodrich CA, Campbell SS, Gillin JC (1988) Increased REM sleep in rats selectively bred for cholinergic hyperactivity. Neuropsychopharmacology:1127–133CrossRefGoogle Scholar
  95. Sonntag A, Rothe B, Guldner J, Yassouridis A, Holsboer F, Steiger A (1996) Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 4:1–13PubMedCrossRefGoogle Scholar
  96. Spiker DG, Coble P, Cofsky J, Foster FG, Kupfer DJ (1978) EEG sleep and severity of depression. Biol Psychiatr 13:485–488Google Scholar
  97. Steiger A (1988) Effects of clomipramine on sleep-EEG and nocturnal penile tumescence (NPT), a long-term study in a healthy man. J Clin Psychopharmacol 8:349–354PubMedCrossRefGoogle Scholar
  98. Steiger A, von Bardeleben U, Herth T, Holsboer F (1989) Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord 16:189–195PubMedCrossRefGoogle Scholar
  99. Steiger A, Gerken A, Benkert O, Holsboer F (1993a) Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls. Eur Neuropsychopharmacol 3:117–126CrossRefGoogle Scholar
  100. Steiger A, von Bardeleben U, Guldner J, Lauer C, Rothe B, Holsboer F (1993b) The sleep EEG and nocturnal hormonal secretion. Studies on changes during the course of depression and on effects of CNS- active drugs. Prog Neuropsychopharmacol Biol Psychiatr 17:125–137Google Scholar
  101. Steiger A, Benkert O, Holsboer F (1994) Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men. Neuropsychobiology 30:101–105PubMedCrossRefGoogle Scholar
  102. Svendsen K, Christensen PG (1981) Duration of REM sleep latency as predictor of effect of antidepressant therapy. A preliminary report. Acta Psychiatr Scand 64:238–243CrossRefGoogle Scholar
  103. Taub JM, Hawkins DR, Van de Castle RL (1978) Electrographic analysis of the sleep cycle in young depressed patients. Biol Psychol 7:203–214PubMedCrossRefGoogle Scholar
  104. Thase ME, Kupfer DJ, Buysse DJ, Frank E, Simons AD, McEachran AB, Rashid KF, Grochocinski VJ (1995) Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states.Biol Psychiatr 38:506–515Google Scholar
  105. Thase ME, Simons AD, Reynolds CF, III (1996) Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy. Arch Gen Psychiatr 53:99–108PubMedCrossRefGoogle Scholar
  106. Thase ME, Kupfer DJ, Fasiczka AJ, Buysse DJ, Simons AD, Frank E (1997) Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder. Biol Psychiatr 41:964–973CrossRefGoogle Scholar
  107. TibaPA, Tufik S, Suchecki D (2004) Effects of maternal separation on baseline sleep and cold stress-induced sleep rebound in adult Wister rats. Sleep 27:1146–1153PubMedGoogle Scholar
  108. Uhde TW, Roy-Byrne P, Gillin JC, Mendelson WB, Boulenger JP, Vittone BJ, Post RM (1984) The sleep of patients with panic disorder: a preliminary report. Psychiatr Res 12:251–259CrossRefGoogle Scholar
  109. Vogel GW (1983) Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Prog Neuropsychopharmacol Biol Psychiatr 7:343–349CrossRefGoogle Scholar
  110. Vogel GW, Thurmond A, Gibbons P, Sloan K, Walker M (1975) REM sleep reduction effects on depression syndromes. Arch Gen Psychiatr 32:765–777PubMedCrossRefGoogle Scholar
  111. Wiegand M, Berger M, Zulley J, von Zerssen D (1986) The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry 19:198–199CrossRefGoogle Scholar
  112. Winokur A, DeMartinis NA, III, McNally DP, Gary EM, Cormier JL, Gary KA (2003) Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiat 64:1224–1229CrossRefGoogle Scholar
  113. Wyatt RJ, Fram DH, Kupfer DJ, Snyder F (1971) Total prolonged drug-induced REM sleep suppression in anxious depressed patients. Arch Gen Psychiatr 24:145–155PubMedCrossRefGoogle Scholar
  114. Zarcone, VP, Jr.Benson KL, Berger PA (1987) Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry 44:45–48PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Neurogenetics of SleepMax Planck Institute of PsychiatryMunichGermany

Personalised recommendations